[
  {
    "ts": null,
    "headline": "Mizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth",
    "summary": "Elevance Health Inc. (NYSE:ELV) is one of the cheap S&P 500 stocks to invest in now. On January 9, Mizuho analyst Ann Hynes raised the firm’s price target on Elevance Health to $413 from $400 and maintained an Outperform rating on the shares. As part of its Q4 2025 preview, Mizuho broadly revised price targets […]",
    "url": "https://finnhub.io/api/news?id=2d77e8ba9571ab1a0222fa3ba04b372b7478b93929ae53c7fb17235a5933ba84",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768413217,
      "headline": "Mizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth",
      "id": 138114822,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health Inc. (NYSE:ELV) is one of the cheap S&P 500 stocks to invest in now. On January 9, Mizuho analyst Ann Hynes raised the firm’s price target on Elevance Health to $413 from $400 and maintained an Outperform rating on the shares. As part of its Q4 2025 preview, Mizuho broadly revised price targets […]",
      "url": "https://finnhub.io/api/news?id=2d77e8ba9571ab1a0222fa3ba04b372b7478b93929ae53c7fb17235a5933ba84"
    }
  }
]